Antibiotic treatment of acute otitis media in pediatrics

Future Microbiology

Volumn 6, Issue 5, 2011, Pages 485-488

  Esposito, Susanna ^a   Marchisio, Paola ^a   Tenconi, Rossana ^a   Principi, Nicola ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

acute otitis media; antibiotic therapy; antibiotics; children; otitis; pediatrics

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; PLACEBO;

ACUTE OTITIS MEDIA; ARTICLE; CHILD; DIAPER DERMATITIS; DIARRHEA; HUMAN; INFANT; PEDIATRICS; PRESCHOOL CHILD; PRIORITY JOURNAL;

EID: 79956161749     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.11.28     Document Type: Article

References (30)

1. Hoberman A, Paradise JL, Rockette HE et al.: Treatment of acute otitis media in children under 2 years of age. N. Engl. J. Med. 364, 105-115 (2011). • A very interesting study showing that 10 days' treatment with amoxicillin-clavulanate tended to reduce the overall symptom burden, the time to symptom resolution and the rate of persistent signs of acute infection upon otoscopic examination in children with acute otitis media (AOM) aged 6-23 months.
2. Teele DW, Klein JO, Rosner B: Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J. Infect. Dis. 160, 83-94 (1989). (Pubitemid 19162997)
3. Pelton SI: Otitis media: re-evaluation of diagnosis and treatment in the era of antimicrobial resistance, pneumococcal conjugate vaccine, and evolving morbidity. Pediatr. Clin. North Am. 52, 711-728 (2005). (Pubitemid 40733591)
4. Greenberg D, Bilenko N, Liss Z: The burden of acute otitis media on the patient and the family. Eur. J. Pediatr. 162, 576-581 (2003). (Pubitemid 37100616)
5. Rovers MM, Schilder AGM, Zielhius GA, Rosenfels RM: Otitis media. Lancet 363, 465-473 (2004). (Pubitemid 38210066)
6. Dowell SF, Marcy SM, Phillips WR, Gerber MA, Schwartz B: Otitis media - principles of judicious use of antimicrobial agents. Pediatrics 101(Suppl.), 165-171 (1998). (Pubitemid 28027853)
7. American Academy of Pediatrics and American Academy of Family Physicians: Diagnosis and management of acute otitis media. Pediatrics 113, 1451-1465 (2004). • Comprehensive guidelines on the approach to pediatric AOM.
8. Leibovitz E, Broides A, Greenberg D, Newman N: Current management of pediatric acute otitis media. Expert Rev. Antinfect. Ther. 8, 151-161 (2010). • An interesting overview of the new treatment guidelines for AOM.
9. Marchisio P, Bellussi L, Di Mauro G et al.: Acute otitis media: From diagnosis to prevention. Summary of the Italian guideline. Int. J. Pediatr. Otorhinolaryngol. 74, 1209-1216 (2010). • Italian guidelines concerning the diagnosis, treatment and prevention of pediatric AOM.
10. Dagan R: Appropriate treatment of acute otitis media in the era of antibiotic resistance. Paediatr. Drugs 29(12 Suppl. 1), 3-9 (2010). • Review aimed at assisting clinicians in better understanding the current recommendations for the treatment of AOM and the steps to be taken when following up AOM patients.
11. Vergison A, Dagan R, Arguedas A et al.: Otitis media and its consequences: Beyond the earache. Lancet Infect. Dis. 10, 195-203 (2010). • Comprehensive review of the controversies surrounding the guidelines on AOM, with suggestions to clinicians and public health officials concerning the actions needed to reduce the disease burden of AOM and microbial antibiotic resistance due to the use of antibiotics.
12. Bain J: Treatment of acute otitis media: Are children entered into clinical trials representative? Br. J. Gen. Pract. 51, 132-133 (2001). (Pubitemid 32117822)
13. Dagan R, McCracken GH Jr: Flaws in design and conduct of clinical trials in acute otitis media. Pediatr. Infect. Dis. J. 21, 894-902 (2002). (Pubitemid 35176147)
14. Marchant CD: Acute otitis media, antibiotics, children and clinical trial design. Pediatr. Infect. Dis. J. 21, 891-893 (2002). (Pubitemid 35176146)
15. Pichichero ME, Casey JR: Diagnostic criteria and subject exclusions render placebo and observational studies of acute otitis media inconclusive. Pediatr. Infect. Dis. J. 27, 958-962 (2008).
16. Pichichero ME, Casey JR: Comparison of study designs for acute otitis media trials. Int. J. Pediatr. Otorhinolaringol. 72, 737-750 (2008).
17. Shaikh N, Hoberman A, Paradise JL et al.: Responsiveness and construct validity of a symptom scale for acute otitis media. Pediatr. Infect. Dis. J. 28, 9-12 (2009).
18. Tähtinen PA, Laine MK, Huovinen P, Jalava J, Ruuskanen O, Ruohola A: A placebo-controlled trial of antimicrobial treatment for acute otitis media. N. Engl. J. Med. 364, 116-126 (2011). • A very interesting study showing that children with acute otitis media benefit more from antimicrobial treatment than placebo despite the greater incidence of side effects.
19. Hoberman A, Paradise JL: Acute otitis media: Diagnosis and management in the year 2000. Pediatr. Ann. 29, 609-620 (2000).
20. Pichichero ME: Acute otitis media - part I: Improving diagnostic accuracy. Am. Fam. Physician 61, 2051-2056 (2000). (Pubitemid 30225612)
21. Marchisio P, Mira E, Klersy C et al.: Medical education and attitudes about the acute otitis media guidelines: An Italian survey of pediatricians and otolaryngologists. Pediatr. Infect. Dis. J. 28, 1-4 (2009).
22. Esposito S, Lizioli A, Lastrico A et al.: Impact on respiratory tract infections of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months of age. Respir. Res. 8, 12 (2007).
23. Jansen AG, Hak E, Veenhoven RH, Damoiseaux RA, Schilder AG, Sanders EA: Pneumococcal conjugate vaccines for preventing otitis media. Cochrane Database Syst. Rev. 2, CD001480 (2009).
24. Grijalva CG, Nuorti JP, Griffin MR: Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA 302, 758-766 (2009).
25. Esposito S, Tansey S, Thompson A et al.: Safety and immunogenicity of 13-valent pneumococcal conjugate vaccine compared with 7-valent pneumococcal conjugate vaccine given as a 3-dose series with routine vaccines in healthy infants and toddlers. Clin. Vaccine Immunol. 17, 1017-1026 (2010). • An interesting study showing the safety and immunogenicity of 13-valent pneumococcal conjugate vaccine administered simultaneously with hexavalent vaccine after 3, 5 and 11 months of age.
26. O'Brien MA, Prosser LA, Paradise JL et al.: New vaccines against otitis media: Projected benefits and cost-effectiveness. Pediatrics 123, 1452-1463 (2009).
27. Hausdorff WP, Dagan R, Beckers F, Schuerman L: Estimating the direct impact of new conjugate vaccines against invasive pneumococcal disease. Vaccine 27, 7257-7269 (2009).
28. Belshe RB, Edwards KM, Vesikari T et al.: Live attenuated versus inactivated influenza vaccine in infants and young children. N. Engl. J. Med. 356, 685-696 (2007). • An interesting study of the immunogenicity and efficacy of intranasal live attenuated influenza vaccine in the first years of life.
29. Marchisio P, Esposito S, Bianchini S et al.: Efficacy of injectable trivalent virosomal-adjuvanted inactivated influenza vaccine in preventing acute otitis media in children with recurrent complicated or non-complicated acute otitis media. Pediatr. Infect. Dis. J. 28, 855-859 (2009).
30. Heinonen S, Silvennoinen H, Lehtinen P, Vainionpää R, Ziegler T, Heikkinen T: Effectiveness of inactivated influenza vaccine in children aged 9 months to 3 years: An observational cohort study. Lancet Infect. Dis. 11, 23-29 (2011). • An interesting study showing the effectiveness of inactivated influenza vaccine in the first years of life.